Literature DB >> 23375476

[Current position of Essure(®) micro-insert in the management of hydrolsalpinges before in vitro fertilization].

C Sonigo1, P Collinet, C Rubod, S Catteau-Jonard.   

Abstract

Tubal diseases are a common cause of female infertility. Among them, hydrosalpinges are frequent. In addition, the presence of hydrosalpinges is a factor of failed attempts at in vitro fertilization (IVG). It is now well recognized that the management of hydrosalpinges prior attempts to medically assisted procreation increases the chances of pregnancy. Nowadays, laparoscopic salpingectomy is the treatment of choice but this therapeutic approach is not consensual and several other surgical techniques have been proven in this indication. Among these, the exclusion of hydrosalpinx by laying Essure(®) micro-inserts seems promising. Currently, seven studies have been published on the topic with generally positive results. The purpose of this article is to review the various possible methods to treat hydrosalpinx before IVF and especially to define the role of Essure(®) micro-inserts.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23375476     DOI: 10.1016/j.gyobfe.2012.12.010

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  2 in total

1.  Discussion on operative skills in the embolization of hydrosalpinx by hysteroscopic placement of a microcoil.

Authors:  Hua-Lei Cai; Le-Yun Pan; Shun-Fang Wang; Yu Tian; Xiao-Zhu Zheng; Yan Yang; Kun Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

2.  Essure Microinsert Abdominal Migration after Hysteroscopic Tubal Sterilization of an Appropriately Placed Essure Device: Dual Case Reports and Review of the Literature.

Authors:  Shadi Rezai; Meghan LaBine; Hunter Azdel Gomez Roberts; Isamarie Lora Alcantara; Cassandra E Henderson; Malvina Elmadjian; Dilfuza Nuritdinova
Journal:  Case Rep Obstet Gynecol       Date:  2015-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.